Literature DB >> 1331299

Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat.

K Rittner1, R Heilbronn, J A Kleinschmidt, G Sczakiel.   

Abstract

Microinjection of wild-type adeno-associated virus type 2 (AAV-2) DNA and infectious human immunodeficiency virus type 1 (HIV-1) proviral DNA into the nuclei of human epithelioid SW480 cells leads to specific inhibition of HIV-1 replication. Mutational analysis of the AAV genome showed that this negative interference can be assigned to a functional AAV-2 rep gene. Moreover, the p78rep/p68rep proteins are sufficient for the anti-HIV-1 effects. The rep gene also inhibits the expression of a chloramphenicol acetyl-transferase (CAT) gene driven by the U3/R portion of the HIV-1 long terminal repeat (LTR) in the absence of tat expression. This suggests that the U3/R portion of HIV-1 contains elements responsible for the AAV-2 rep-mediated inhibition of HIV-1 LTR-driven CAT gene expression and, probably, also of HIV-1 replication. The results add support for the general significance of AAV-2 and specifically the rep gene as tools for down-regulating heterologous gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331299     DOI: 10.1099/0022-1317-73-11-2977

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.

Authors:  J Wu; M D Davis; R A Owens
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  PKA/PrKX activity is a modulator of AAV/adenovirus interaction.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

3.  Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.

Authors:  K A Vincent; S T Piraino; S C Wadsworth
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene.

Authors:  R S Wonderling; R A Owens
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Identification of an adeno-associated virus Rep protein binding site in the adenovirus E2a promoter.

Authors:  John M Casper; Jennifer M Timpe; John David Dignam; James P Trempe
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line.

Authors:  Dawn P Wooley; Priyanka Sharma; John R Weinstein; Poornima Kotha Lakshmi Narayan; David V Schaffer; Katherine J D A Excoffon
Journal:  J Virol Methods       Date:  2017-09-14       Impact factor: 2.014

7.  Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers.

Authors:  M D Weitzman; K J Fisher; J M Wilson
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats.

Authors:  J H Ryan; S Zolotukhin; N Muzyczka
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

Authors:  S R Kyöstiö; R S Wonderling; R A Owens
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.

Authors:  D M McCarty; D J Pereira; I Zolotukhin; X Zhou; J H Ryan; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.